Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2
Angelika Eisele-Metzger, Judith-Lisa Lieberum, M. Toews, Waldemar Siemens, Felix Heilmeyer, Christian Haverkamp, D. Boehringer, Joerg J. Meerpohl
medRxiv